According to the company's website and safety disclosures, you may qualify if: Your Body Mass Index (BMI) is 30 or higher (classified as obese), OR Your BMI is 27 or higher with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, obstructive sleep apnea, or cardiovascular disease, OR Your BMI is above 25 and you may still qualify depending on your overall medical history, as determined by the licensed provider The evaluating clinician reviews your full medical history during intake and makes the final determination about whether treatment is appropriate and safe for your specific situation
In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have been used to control blood glucose levels in patients with diabetes
The lower-cost doses will be offered only through Lillys telehealth platform, LillyDirect, however, and they wont be covered by insurance, meaning patients will need to pay for them in cash
$6 for a 4-pack at most grocery stores
Instead, Pfizers twice-a-day pill, danuglipron, will be advanced toward late-stage testing as the company attempts to tap into the white-hot weight-loss market led by Novo Nordisk and Eli Lilly
These events were usually mild or moderate